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Abstract
The insulin/insulin-like growth factor-1 (IGF-1) pathway drives an evolutionarily conserved network that regulates
lifespan and longevity. Individuals with Laron syndrome who carry mutations in the growth hormone receptor
(GHR) gene that lead to severe congenital IGF-1 deficiency with decreased insulin/IGF-1 signaling (IIS) exhibit
reduced prevalence rates of acne, diabetes and cancer. Western diet with high intake of hyperglycemic
carbohydrates and insulinotropic dairy over-stimulates IIS. The reduction of IIS in Laron subjects unmasks the
potential role of persistent hyperactive IIS mediated by Western diet in the development of diseases of civilization
and offers a rational perspective for dietary adjustments with less insulinotropic diets like the Paleolithic diet.
Introduction
Recently, Guevara-Aguirre et al reported on 99 Ecua-
dorian individuals with Laron syndrome due to growth
hormone receptor (GHR) deficiency and congenital
insulin-like growth factor-1 (IGF-1) deficiency who did
not develop type 2 diabetes (T2D) and were almost free
of cancer, in contrast to their healthy relatives with nor-
mal insulin/IGF-1 signaling (IIS) [1]. A recent worldwide
survey of Steuerman et al demonstrated that none of
230 individuals with Laron syndrome developed cancer
[2]. Laron syndrome is a very informative experiment of
nature and uncovers the link between low IIS and the
related protection from diseases of civilization in con-
trast to exaggerated IIS induced by Western diet as
shown in Figure 1.
Insulin/IGF-1/FoxO signaling in nonhuman organisms
Over 20 years ago it was discovered that mutations in
daf-2 and age-1 double the lifespan in worms [3,4]. Daf-
2 encodes the only insulin/IGF-1 receptor expressed in
worms and age-1 is the catalytic subunit of the down-
stream phosphoinositide 3-kinase (PI3K). Substantial
evidence has been provided that IIS is an evolutionarily
conserved pathway that regulates lifespan across many
species like flies, worms, and mice [3-6]. Decreased IIS
in nonhuman organisms has been associated with
extended lifespan and protection against oxidative
stress-mediated age-dependent damage [5,6]. IIS acti-
vates PI3K and Akt kinase. Akt-mediated phosphoryla-
tion activates the kinase mammalian target of rapamycin
complex 1 (mTORC1) activating its effector S6 kinase 1
(S6K1) involved in the up-regulation of protein synthesis
and cell proliferation. Furthermore, activated Akt stimu-
lates specific phosphorylation of FoxO proteins in the
nucleus leading to their extrusion into the cytoplasm
[5]. FoxO transcription factors have emerged as a con-
vergence point of IIS, nutrient availability and oxidative
stress [6]. Increased expression of DAF-16, the ortholog
of human FoxO proteins in the worm Caenorhabditis
elegans, due to a mutation of the insulin/IGF-1 receptor
daf-2 has been found to significantly increase the
worm’s lifespan [2,3]. Male and female heterozygous
IGF-1 receptor knockout mice Igf1r
+/- live 16% and 33%
longer than wild-type males and females, respectively
[7]. Thus, convincing experimental evidence obtained
from invertebrates and nonhuman vertebrates taught us
that down-regulated IIS is of critical importance for
metabolic homeostasis, improved oxidative stress
responses and longevity.
The pathogenesis of age-related diseases has been
associated with an impaired capacity to counteract
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some of the consequences of an oxidative environment
are the development of insulin resistance, b-cell dys-
function, impaired glucose tolerance, and mitochondrial
dysfunction [8]. Oxidative stress, implicated in the etiol-
ogy of cancer, results from an imbalance in the produc-
tion of reactive oxygen species (ROS) and the cell’so w n
antioxidant protection. ROS deregulate the redox home-
ostasis and promote tumor formation by initiating an
aberrant induction of signaling networks that cause
tumorigenesis [9]. FoxO proteins are pivotal regulators
of oxidative stress resistance and activate the expression
of manganese superoxide dismutase and catalase [5].
Moreover, FoxO1 at the promoter level induces expres-
sion of Hmox1 (heme oxygenase 1) thereby decreasing
mitochondrial respiration and ROS formation [5]. Thus,
increased IIS with down-regulated nuclear FoxO levels
impairs adequate elimination of ROS, a critical mechan-
ism involved in the promotion of acne, T2D and cancer.
Insulin/IGF-1/FoxO signaling and type 2 diabetes
FoxO1 inhibits b-cell proliferation [10]. Nutritional
alterations of b-cell FoxO1 transcriptional activity are
predominantly mediated through glucose-stimulated
insulin secretion and insulin receptor signaling.
Recently, the concept of a “metabolic diapause” has
been proposed for the changes induced by FoxO1 to
protect b-cells against oxidative stress underpinning the
concept of b-cell rest as a treatment goal in T2D [11].
Thus, FoxO1, the convergence point of IIS, orchestrates
b-cell proliferation and apoptosis which both are
increased in T2D [12].
Insulin/IGF-1/FoxO signaling and cancer
GH, IGF-1 and insulin have cancer-promoting actions
and raised serum IGF-1 levels have been associated with
increased risk of prostate, breast and colorectal cancers
[13]. Steuerman et al conducted a large worldwide sur-
vey on the prevalence of cancer in patients with various
causes of secondary congenital IGF-1 deficiency and
confirmed that subjects with Laron syndrome with con-
genital IGF-1 deficiency seem protected from the devel-
opment of cancer [2]. IIS regulates the nuclear
distribution of FoxO proteins which are increasingly
considered to represent unique cellular targets directed
against human cancer in light of their pro-apoptotic
effects and their ability to lead to cell cycle arrest [5,14].
FoxOs are involved in the control of angiogenesis, stem
cell proliferation, cell adhesion, oxidative stress
responses, as well as innate and acquired immunity. Per-
manently increased IIS with consecutive down-regula-
tion of nuclear FoxO levels may thus promote the
development of cancer [14].
Insulin/IGF-1/FoxO signaling and acne
Acne is epidemic in adolescents of Western life style
and absent in populations consuming a Paleolithic diet
excluding sugar, grains and dairy like the Kitava islan-
ders who exhibit low basal insulin levels compared with
age-matched Europeans [15]. Accumulating evidence
supports the view that consumption of hyperglycemic
carbohydrates and insulinotropic dairy are the driving
force of the acne epidemic in Western countries [16].
IGF-1 is a strong stimulator of sebaceous lipogenesis
and acne pathogenesis has been linked to elevated IIS
with consecutive nuclear FoxO deficiency [16,17]. More-
over, IGF-1 stimulates androgen receptor signaling by
increasing adrenal and gonadal androgen synthesis as
well as androgen receptor transactivation by nuclear
extrusion of the androgen receptor cosuppressor FoxO1
[17,18]. Thus, acne can be considered as a visible model
disease of exaggerated IIS during puberty aggravated by
Western diet, just the opposite of deficient IIS in
untreated Laron subjects who do not develop acne [19].
On the other hand, seborrhea, acne, T2D and cancer
are frequently observed in acromegaly with increased
GH/IGF-1 signaling in comparison to healthy controls
[16]. Intriguingly, an association between the prevalence
of severe tetracycline-treated acne and increased risk of
prostate cancer later in life has been observed [20].
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Figure 1 Impact of insulin/IGF-1 signaling in Laron syndrome
(A) and Western diet (B) on FoxO-mediated gene regulation
and associated pathologies. GHR*, growth hormone receptor loss
of function mutation in Laron syndrome; GIP, glucose-dependent
insulinotropic polypeptide, a whey protein-induced incretin, which
stimulates b-cell proliferation and insulin secretion; PRL, prolactin;
PRL secretion is induced by serotoninergic hypothalamic signaling;
Trp, tryptophan, and Leu, leucine, essential amino acids enriched in
the whey protein a-lactalbumin; Trp via serotonin synthesis
stimulates pituitary GH and PRL secretion and Leu stimulates b-cell
proliferation and insulin secretion.
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Grain-based food, sugars and dairy products are the
nutritional staples of Western diet. High glycemic load
diets have been recognized as aggravating factors of
acne, whereas a low glycemic load diet improved acne
and decreased the bioavailability of free IGF-1 in plasma
[21].
Milk and fermented dairy products containing whey
proteins exhibit a high insulinemic index in comparison
to their low carbohydrate content [22]. This phenom-
enon appears to be the secret of IIS of mammalian milk,
an evolutionarily provided program for the promotion
of neonatal growth [16]. Cow milk consumption in
humans shifts the somatotropic axis to higher levels and
significantly increases serum levels of GH and IGF-1
[23] (Figure 1B). Oral ingestion of the whey protein a-
lactalbumin has been shown to increase the somatotro-
pic axis in healthy women. There is strong epidemiolo-
gical evidence that dairy consumption significantly
increases serum IGF-1 levels in humans [24]. This
explains why high intake of milk increases linear growth
[25]. In contrast, short stature is a characteristic feature
of congenital IGF-1 deficiency in Laron syndrome.
Thus, Western diet shifts the GH/IGF-1 axis to abnor-
mally high levels, just in the opposite direction of low
IIS observed in Laron syndrome [1,2] (Figure 1).
Exaggerated insulin/IGF-1 signaling by Western diet and
type 2 diabetes
Insulin resistance and hyperinsulinemia are characteris-
tic features of the metabolic syndrome. Extensive con-
sumption of hyperglycemic food with increased glucose-
mediated signal transduction to pancreatic b-cells is a
major factor of glucose/FoxO1-mediated b-cell prolifera-
tion and impaired b-cell oxidative stress responses
[8-11].
Milk consumption after the weaning period maintains
high levels of IIS persistently stimulating pancreatic b-
cell proliferation [26]. Continued over-stimulation of
pancreatic b-cells by whey protein-driven IIS after the
post-weaning period may continuously diminish nuclear
FoxO levels, thereby promoting oxidative stress damage
of b-cells finally resulting in early onset of b-cell cellular
senescence and apoptosis [26]. Indeed, increased prolif-
eration and apoptosis of b-cells during lifetime are hall-
marks of T2D [12].
Exaggerated insulin/IGF-1 signaling of Western diet and
cancer
Increased IIS has been implicated to play an important
role in most types of epithelial neoplasia [13,27]. Higher
serum IGF-1 levels were associated with increased risk
of cancer death in older community-dwelling men [28].
On the other hand, subjects with Laron syndrome
exemplify that low IIS is associated with a low preva-
lence of cancer [1,2]. However, it should be mentioned
that Laron subjects are not longer lived than normal
subjects eating a Western diet and if not properly trea-
ted die of cardiovascular diseases.
Conclusion and future perspectives
Laron syndrome with decreased IIS is associated with a
reduced prevalence of acne, T2D and cancer. In con-
trast, up-regulated IIS by Western diet appears to pro-
mote the development of chronic diseases of civilization.
Paleolithic diet, which excludes hyperglycemic carbohy-
drates and insulinotropic dairy, has been successfully
introduced for the prevention and treatment of acne,
T2D and cardiovascular diseases [16,29]. Future efforts
should be undertaken to lower the high insulinemic
index of milk (I.I. 140) and other whey-based milk pro-
ducts to reach values of beef (I.I. 51) or cheese (I.I. 45)
[16,29]. Furthermore, combinations of hyperglycemic
carbohydrates and insulinotropic dairy with potentiating
effects on IIS should be restricted.
Individuals with genetic single nucleotide polymorph-
isms (SNPs) resulting in hyperactive IIS may be at spe-
cial risk for the development of age-related diseases,
predominantly when their high intrinsic IIS is super-
posed by exaggerated IIS of Western diet. Intriguingly,
genetic variations with reduced IIS due to SNPs of inter-
acting components of the IIS cascades (GH1, IGF1,
IGF1R, IRS1, FoxO1A, FoxO3A) and have been asso-
ciated with increased longevity [30,31]. Thus, future
research should consider the impact of interacting
intrinsic genetic as well as extrinsic dietary factors
involved in the regulation of IIS.
The access to higher amounts of insulinotropic and
IGF-1-raising foods (sugar, grains and dairy) occurred
about 10,000 years ago during the Neolithic Revolution
and was further augmented by the Industrial Revolution.
However, the human genome may not have adapted to
this “recent switch” to higher IIS driven by Western diet.
According to mitochondrial DNA data, modern humans
with nearly similar genomic structure lived roughly
200,000 years ago and consumed a less insulinotropic
Paleolithic diet. In this regards, it has been proposed to
re-adapt our nutrition to the beneficial characteristics of
our pre-agricultural diets [32]. The time point introdu-
cing a well-balanced Paleolithic diet may be a special
issue of concern as proper IIS is important for the func-
tion of the reproductive and central nervous system. In
adulthood however, dietary restrictions decreasing IIS
may reduce the risk of age-associated pathology like pro-
teotoxicity as recently demonstrated in a mouse model of
Alzheimer disease [33].
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